Yahoo
LSE - Delayed Quote GBp

Futura Medical plc (FUM.L)

0.1750 -0.0140 (-7.41%)
At close: October 30 at 4:35:20 PM GMT
Chart Range Bar
Loading chart for FUM.L
  • Previous Close 0.1890
  • Open 0.1800
  • Bid 0.1750 x --
  • Ask 0.1800 x --
  • Day's Range 0.1600 - 0.2000
  • 52 Week Range 0.1600 - 2.8000
  • Volume 8,255,692
  • Avg. Volume 10,178,697
  • Market Cap (intraday) 2.594M
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

www.futuramedical.com

13

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

FUM.L
84.30%
FTSE 100 (^FTSE)
8.04%

1-Year Return

FUM.L
93.28%
FTSE 100 (^FTSE)
9.94%

3-Year Return

FUM.L
99.44%
FTSE 100 (^FTSE)
46.43%

5-Year Return

FUM.L
99.52%
FTSE 100 (^FTSE)
48.25%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -158.21%

  • Return on Assets (ttm)

    -40.08%

  • Return on Equity (ttm)

    -145.13%

  • Revenue (ttm)

    2.32M

  • Net Income Avi to Common (ttm)

    -3.67M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.24M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.96M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: